The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma

Cancer

Volumn 118, Issue 10, 2012, Pages 2682-2692

  Riad, Soha ^a,b   Biau, David ^a,b   Holt, Ginger E ^c   Werier, Joel ^d   Turcotte, Robert E ^e   Ferguson, Peter C ^a,b,f   Griffin, Anthony M ^a,b   Dickie, Colleen I ^b   Chung, Peter W ^b   Catton, Charles N ^b   O'Sullivan, Brian ^b   Wunder, Jay S ^a,b,f  

^a MOUNT SINAI HOSPITAL   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

functional outcome; limb salvage surgery; postirradiation; radiation induced; soft tissue sarcoma

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANGIOSARCOMA; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLITIS; DEBRIDEMENT; DEEP VEIN THROMBOSIS; DISEASE FREE INTERVAL; FEMALE; FIBROSIS; FUNCTIONAL ASSESSMENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG EMBOLISM; LYMPHEDEMA; LYMPHOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED NEOPLASM; RADIATION RESPONSE; RADIATION SAFETY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOFT TISSUE SARCOMA; SURVIVAL RATE; WOUND COMPLICATION; WOUND DRESSING; WOUND IRRIGATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY DOSAGE; SARCOMA; TIME FACTORS;

EID: 84857960470     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26543     Document Type: Article

References (54)

1. Davis AM, O'sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005; 75: 48-53.
2. Davis AM, O'sullivan B, Bell RS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 2002; 20: 4472-4477.
3. O'sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002; 359: 2235-2241.
4. Mark RJ, Poen J, Tran LM, Fu YS, Selch MT, Parker RG,. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer. 1994; 73: 2653-2662.
5. Huvos A,. Bone Tumours: Diagnosis, Treatment and Prognosis. 2nd ed. Philadelphia, PA: WB Saunders Company; 1991.
6. Wiklund TA, Blomqvist CP, Raty J, Elomaa I, Rissanen P, Miettinen M,. Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer. 1991; 68: 524-531.
7. Sheppard DG, Libshitz HI,. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol. 2001; 56: 22-29.
8. Amendola BE, Amendola MA, McClatchey KD, Miller CH Jr,. Radiation-associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am J Clin Oncol. 1989; 12: 411-415.
9. Inoue YZ, Frassica FJ, Sim FH, Unni KK, Petersen IA, McLeod RA,. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol. 2000; 75: 42-50.
10. Cahan WG, Woodard HQ, et al. Sarcoma arising in irradiated bone: report of 11 cases. Cancer. 1948; 1: 3-29.
11. Arlen M, Higinbotham NL, Huvos AG, Marcove RC, Miller T, Shah IC,. Radiation-induced sarcoma of bone. Cancer. 1971; 28: 1087-1099.
12. Gerrand CH, Wunder JS, Kandel RA, et al. Classification of positive margins after resection of soft tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg. 2001; 83B: 1149-1155.
13. Davis AM, Wright JG, Williams JI, Bombardier C, Griffin AM, Bell RS,. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996; 5: 508-516.
14. Enneking W,. Modification of the system for functional evaluation of the surgical management of musculoskeletal tumors. In:, Enneking W, ed. Limb Salvage in Musculoskeletal Oncology. New York: Churchill Livingstone; 1987: 626-639.
15. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
16. Cox DR,. Regression models and life tables. J R Stat Soc B. 1972; 34: 187-220.
17. Harrell F,. Regression Modelling Strategies. New York: Springer-Verlag; 2001.
18. Sobin L, Gospodarowicz M, Wittekind C, eds. TNM Classification of Malignant Tumours. 7th ed. New York: Wiley-Blackwell; 2009.
19. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31: 1341-1346.
20. Stern TN,. Clinical Examination: A Textbook for Physical Diagnosis. Chicago, IL: Year Book Medical Publishers; 1964.
21. Gladdy RA, Qin LX, Moraco N, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010; 28: 2064-2069.
22. Fang Z, Matsumoto S, Ae K, et al. Postradiation soft tissue sarcoma: a multiinstitutional analysis of 14 cases in Japan. J Orthop Sci. 2004; 9: 242-246.
23. Thijssens KM, van Ginkel RJ, Suurmeijer AJ, et al. Radiation-induced sarcoma: a challenge for the surgeon. Ann Surg Oncol. 2005; 12: 237-245.
24. Koea JB, Leung D, Lewis JJ, Brennan MF,. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol. 2003; 10: 432-440.
25. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer. 2003; 97: 2530-2543.
26. Wunder JS, Healey JH, Davis AM, Brennan MF,. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer. 2000; 88: 2721-2730.
27. Shaheen M, Deheshi BM, Riad S, et al. Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res. 2006; 450: 76-81.
28. Bielack SS, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K,. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol. 1999; 17: 1164.
29. Tabone MD, Terrier P, Pacquement H, et al. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases. J Clin Oncol. 1999; 17: 2789-2795.
30. Koshy M, Paulino AC, Mai WY, Teh BS,. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys. 2005; 63: 1169-1174.
31. Waddell AE, Davis AM, Ahn H, Wunder JS, Blackstein ME, Bell RS,. Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups. Can J Surg. 1999; 42: 190-199.
32. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992; 10: 5-15.
33. Adjuvant chemotherapy for localized resectable soft tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-Analysis Collaboration Lancet. 1997; 350: 1647-1654.
34. Nakanishi H, Tomita Y, Myoui A, et al. Mutation of the p53 gene in postradiation sarcoma. Lab Invest. 1998; 78: 727-733.
35. Gonin-Laurent N, Gibaud A, Huygue M, et al. Specific TP53 mutation pattern in radiation-induced sarcomas. Carcinogenesis. 2006; 27: 1266-1272.
36. Kony SJ, de Vathaire F, Chompret A, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet. 1997; 350: 91-95.
37. Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF,. Jr The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer. 2005; 103: 2391-2396.
38. Cha C, Antonescu CR, Quan ML, Maru S, Brennan MF,. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg. 2004; 239: 903-909; discussion 909-910.
39. Neuhaus SJ, Pinnock N, Giblin V, et al. Treatment and outcome of radiation-induced soft-tissue sarcomas at a specialist institution. Eur J Surg Oncol. 2009; 35: 654-659.
40. Gortzak Y, Lockwood GA, Mahendra A, et al. Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh. Cancer. 2010; 116: 1553-1559.
41. Catton C, Davis A, Bell R, et al. Soft tissue sarcoma of the extremity. Limb salvage after failure of combined conservative therapy. Radiother Oncol. 1996; 41: 209-214.
42. Moureau-Zabotto L, Thomas L, Bui BN, et al. Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 cases. Radiother Oncol. 2004; 73: 313-319.
43. Pearlstone DB, Janjan NA, Feig BW, et al. Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am. 1999; 5: 26-33.
44. Laskin WB, Silverman TA, Enzinger FM,. Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer. 1988; 62: 2330-2340.
45. Davidson T, Westbury G, Harmer CL,. Radiation-induced soft-tissue sarcoma. Br J Surg. 1986; 73: 308-309.
46. Virtanen A, Pukkala E, Auvinen A,. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients. Int J Cancer. 2006; 118: 1017-1021.
47. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol. 1996; 14: 2818-2825.
48. Le Vu B, de Vathaire F, Shamsaldin A, et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer. 1998; 77: 370-377.
49. Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst. 1996; 88: 270-278.
50. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987; 317: 588-593.
51. Samartzis D, Nishi N, Hayashi M, et al. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki [published online ahead of print March 31, 2011]. J Bone Joint Surg Am. 2011.
52. Hall EJ, Wuu CS,. Radiation-induced second cancers: the impact of 3DCRT and IMRT. Int J Radiat Oncol Biol Phys. 2003; 56: 83-88.
53. Glatstein E,. Intensity-modulated radiation therapy: the inverse, the converse and the perverse. Semin Radiat Oncol. 2002; 12: 272-281.
54. Nutting C, Dearnaley DP, Webb S,. Intensity modulated radiation therapy: a clinical review. Br J Radiol. 2000; 73: 459-469.